A new U.S. Food and Drug Administration (FDA) guidance is designed to help practitioners conduct clinical trials that often feature relatively delicate young patient populations struggling with attention deficit hyperactivity […]
Clinical trial professionals are muddling through when it comes to grappling with technology day-to-day on the job, with about one-third of those responding to an in-depth survey saying the systems […]
A new draft guidance from the Food and Drug Administration (FDA) beefs up some of the recommendations in the International Council for Harmonization (ICH) E9 Statistical Principle for Clinical Trials […]